<- Go Home
Akoya Biosciences, Inc.
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions for transforming discovery, clinical research, and diagnostics in North America, the Asia-Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. Akoya Biosciences, Inc. was incorporated in 2015 and is headquartered in Marlborough, Massachusetts. As of July 8, 2025, Akoya Biosciences, Inc. operates as a subsidiary of Quanterix Corporation.
Market Cap
$64.4M
Volume
349.0K
Cash and Equivalents
$20.4M
EBITDA
-$30.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$49.4M
Profit Margin
61.74%
52 Week High
$3.42
52 Week Low
$0.93
Dividend
N/A
Price / Book Value
-10.92
Price / Earnings
-1.34
Price / Tangible Book Value
-1.69
Enterprise Value
$120.6M
Enterprise Value / EBITDA
-4.30
Operating Income
-$37.4M
Return on Equity
354.27%
Return on Assets
-17.49
Cash and Short Term Investments
$27.5M
Debt
$83.7M
Equity
-$5.9M
Revenue
$80.0M
Unlevered FCF
-$8.7M
Sector
Life Sciences Tools and Services
Category
N/A